endothelial lipase antisense inhibitors (Isis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameendothelial lipase antisense inhibitors (Isis)
Drug Alias NameELASO (Isis)ELASO
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionLipase inhibitors
TargetsLipase
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A